Latest news with #AmandaBaldwin
Business of Fashion
8 hours ago
- Business
- Business of Fashion
Beauty Chases Its New Rocket Ships
Beauty is on the hunt for its next big bang. The industry has seen a deceleration in sales growth since last year, but pockets of dynamism like the buoyancy of the premium fragrance category and a few recent billion-dollar acquisitions assured investors. In the most recent earnings cycle, many of the world's biggest firms are lowering their targets, and warning of further narrowing in sales. 'In cosmetics, sequentially, the consumer either isn't coming back or is spending a bit less than they were,' said David Hayes, a managing director at the investment bank Jefferies. On Tuesday, La Prairie and Chantecaille parent company Beiersdorf unexpectedly cut its full-year organic sales forecast to grow 3 to 4 percent on softer demand for mass brand Nivea. Conglomerates including Edgewell and Colgate-Palmolive have lowered their guidance, while Helen of Troy and E.l.f. Beauty have declined to issue any. Even the industry's more resilient companies like L'Oréal and E.l.f. Beauty are seeing sales increases slimmer in growth than previous quarters. And for the better part of the year, firms like Coty, Shiseido, Procter & Gamble and The Estée Lauder Companies have announced restructuring programmes and plans to lay off thousands of workers globally. The industry's tried-and-true methods to boost earnings now feel fragile. Retailers from Sephora to Target are losing ground to Amazon and TikTok. Budding tariffs and increased competition in the world's biggest beauty market, the US, are snarling up supply chains, while there's also cooling in the can't-be-beat fragrance and dermatological skincare categories. Nimble indie brands are also relentless in pace and speed. Olaplex's chief executive, Amanda Baldwin, told The Business of Beauty that the premium hair care line is well aware of the need to stay competitive: 'Regenerating the brand demand… is necessary to continue to get [Olaplex] back to growth,' she said last week. Many companies forecast growth of less than 5 percent. Tarang Amin, chief executive of E.l.f. Beauty, told The Business of Beauty that despite his company's continued growth, there is fear and uncertainty in every consumer category. 'We've been able to buck the [downward] trend, but certainly [the climate] weighs on long-term growth,' he said. Crucially, many companies have also run out of road when it comes to price increases. 'It's going to be tough in this environment to pass on even more pricing,' said Filippo Falorni, a managing director at the investment bank Citi, referencing the rising cost of living in many developed economies. 'This is not like the post-Covid era where everyone was getting back into beauty and these companies could increase the price of almost any product,' he said. Growth Vectors Are Cooling Two of beauty's most reliably robust categories, fragrance and dermatological skincare, aren't as resilient as they once were. L'Oréal's Luxe division, which houses the likes of Valentino and Yves Saint Laurent Beauté perfumes, slowed 2 percent. LVMH's beauty division, which includes Dior and Guerlain scents, eked out 1 percent growth. And Barclays investment bank expects Puig — which has around 70 percent of its sales come from fragrance — to see its sales growth to be at the lower end of its guidance of 6-8 percent this financial year. While demand remains high, analysts warn fragrance will not be the saving grace it once was, partially as companies lap tough comparison bases and consumer fatigue. Fragrance is growing, albeit at a slower rate. Many fragrances are also produced within the European Union and sold globally. Presently, EU imports are faced with a 15 percent tariff, though US president Donald Trump has warned it could spike higher if other desired covenants are not met. According to data from Euromonitor, the growth of the fragrance category has sequentially declined from 15 percent in 2021 to 11 percent in 2024. In a July note, Barclays also highlighted softness in the American dermatological skincare market, a category that has become around 15 percent of the overall global skincare market. The declining popularity of drugstores, a key channel for dermatological skincare, has been a drag, as well as customer fatigue with premiumisation. L'Oréal's chief executive noted in its August earnings call that mass brand Cerave, once white-hot and now slowing somewhat, is 'still not as great as [it] would like,' despite a launch into haircare. With a more pronounced deceleration in two of the industry's biggest categories, underlying misses are becoming more visible — for Coty, fragrance helped conceal how much its mass brands like Covergirl and Bourjois were slipping. The Channel Question As more beauty shopping happens online, companies have to spend more on performance marketing and customer acquisition. According to Barclays research, around 17 percent of beauty sales happened online in 2024. While the cost of clicks on Meta platforms dropped around 10 percent in the first five months of the year, they remain high on platforms like Google, and turning a click into conversion is difficult. 'A company might be spending the same amount of money to get the customer [online], but the fickleness of the customer is going up seemingly all the time,' said Hayes, adding that the upfront costs and long-term retention costs for each customer can be more complex. Still, there are bright spots: Amin told The Business of Beauty that E.l.f. Beauty's retention and traffic on TikTok has rebounded after dipping in the first quarter of the year, thanks to some attention-grabbing marketing stunts with trending creators and riffs on viral trends and renewed customer interest. Many premium and mass brands including L'Oréal's Lancôme and Estée Lauder Companies' Origins, Clinique and Aveda have successfully launched on Amazon or TikTok Shop and count those channels as a boon. Long-term, however, maximising spend could become trickier as customers continually hunt for deals and prioritise promotions. It also complicates exclusivity agreements between brands and select retailers — premium brands would historically launch exclusively in a single retailer such as Sephora or Nykaa in the hopes of getting better placement and better conversion, but those bonds are under pressure as customer shopping habits become more fragmented. Price Point Pressure Many beauty companies that sell both mass and prestige products like L'Oréal and Estée Lauder Companies face something of a pincer effect. Customers are looking for value, putting pressure on brands such as Beiersdorf's Nivea and Unilever's Vaseline, both of which have introduced more premium offerings since 2020, while fast-moving brands like E.l.f. Beauty squeeze from the lower end of the pricing spectrum. As consumption slows, companies face the difficult choice of upping prices. Many public conglomerates are focussing on protecting their margins and profits rather than ratcheting up sales, which can work in the medium-term: L'Oréal missed top line expectations, but beat on profits, therefore its earnings impact was relatively low. Positive signs are emerging from previously parched markets. China's 6.18 shopping festival in June was better than expected, with Citi research finding that gross merchandise value increased around 10 percent with fewer discounts. L'Oréal saw growth in China for the first time in over five quarters while Procter & Gamble's chief financial officer Andre Schulten noted on a call in July with analysts that the consumption had been 'relatively strong'. But all companies are facing a renewed call to sharpen their offerings and calibrate prices accordingly. 'Unless you're actually giving people better value for money, you're not winning. That's the problem,' said Hayes. Sign up to The Business of Beauty newsletter, your complimentary, must-read source for the day's most important beauty and wellness news and analysis.
Yahoo
08-05-2025
- Business
- Yahoo
Olaplex (NASDAQ:OLPX) Reports Upbeat Q1 But Stock Drops
Hair care company Olaplex (NASDAQ:OLPX) reported Q1 CY2025 results topping the market's revenue expectations , but sales fell by 1.9% year on year to $96.98 million. The company's full-year revenue guidance of $420.5 million at the midpoint came in 0.6% above analysts' estimates. Its GAAP loss of $0 per share was in line with analysts' consensus estimates. Is now the time to buy Olaplex? Find out in our full research report. Revenue: $96.98 million vs analyst estimates of $93.34 million (1.9% year-on-year decline, 3.9% beat) EPS (GAAP): $0 vs analyst estimates of $0 (in line) Adjusted EBITDA: $25.66 million vs analyst estimates of $22.62 million (26.5% margin, 13.4% beat) The company reconfirmed its revenue guidance for the full year of $420.5 million at the midpoint Operating Margin: 8.7%, down from 19.8% in the same quarter last year Market Capitalization: $885.5 million Amanda Baldwin, OLAPLEX's Chief Executive Officer, commented: "We had a solid start to the year as the quarter marked continued progress on our transformation and our Bonds and Beyond strategy, with first quarter sales coming in ahead of our expectations. As we look ahead, we believe in our ability to navigate the dynamic environment and will continue to invest behind our strategic priorities." Rising to fame on TikTok because of its 'bond building" hair products, Olaplex (NASDAQ:OLPX) offers products and treatments that repair the damage caused by traditional heat and chemical-based styling goods. A company's long-term performance is an indicator of its overall quality. Any business can have short-term success, but a top-tier one grows for years. With $420.7 million in revenue over the past 12 months, Olaplex is a small consumer staples company, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and negotiating leverage with retailers. As you can see below, Olaplex's demand was weak over the last three years. Its sales fell by 14.2% annually, a poor baseline for our analysis. This quarter, Olaplex's revenue fell by 1.9% year on year to $96.98 million but beat Wall Street's estimates by 3.9%. Looking ahead, sell-side analysts expect revenue to remain flat over the next 12 months. Although this projection suggests its newer products will fuel better top-line performance, it is still below the sector average. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) stock benefiting from the rise of AI. Click here to access our free report one of our favorites growth stories. Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king. Olaplex has shown terrific cash profitability, driven by its lucrative business model that enables it to reinvest, return capital to investors, and stay ahead of the competition. The company's free cash flow margin was among the best in the consumer staples sector, averaging an eye-popping 35.3% over the last two years. We were impressed by how Olaplex beat analysts' revenue and EBITDA expectations this quarter. On the other hand, its gross margin missed. Zooming out, we think this was a solid print. The market seemed to be hoping for more, and the stock traded down 6.8% to $1.23 immediately following the results. So should you invest in Olaplex right now? The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here, it's free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
08-05-2025
- Business
- Associated Press
OLAPLEX Reports First Quarter 2025 Results
New York, NY, May 08, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ('OLAPLEX' or the 'Company') today announced financial results for the first quarter ended March 31, 2025. Amanda Baldwin, OLAPLEX's Chief Executive Officer, commented: 'We had a solid start to the year as the quarter marked continued progress on our transformation and our Bonds and Beyond strategy, with first quarter sales coming in ahead of our expectations. As we look ahead, we believe in our ability to navigate the dynamic environment and will continue to invest behind our strategic priorities.' For the first quarter of 2025 compared to the first quarter of 2024: Three Months Ended March 31, 2025 Results Adjusted gross profit, adjusted gross profit margin, adjusted SG&A, adjusted EBITDA and adjusted EBITDA margin are measures that are not calculated or presented in accordance with generally accepted accounting principles in the United States of America ('GAAP'). For more information about how we use these non-GAAP financial measures in our business, the limitations of these measures, and a reconciliation of these measures to the most directly comparable GAAP measures, please see 'Disclosure Regarding Non-GAAP Financial Measures' and the reconciliation tables that accompany this release. Balance Sheet As of March 31, 2025, the Company had $580.9 million of cash and cash equivalents, compared to $586.0 million as of December 31, 2024. Inventory at the end of the first quarter of 2025 was $79.2 million, compared to $75.2 million at December 31, 2024. Long-term debt, net of current portion and deferred debt issuance costs was $642.4 million as of March 31, 2025, compared to $643.7 million as of December 31, 2024. On May 1, 2025, the Company voluntarily repaid $300.0 million of outstanding long-term debt. The repayment was funded using available cash on hand and did not result in prepayment penalties or fees. Fiscal Year 2025 Guidance The Company is reiterating guidance for net sales, adjusted gross profit margin and adjusted EBITDA margin for fiscal year 2025, as initially disclosed by the Company on March 4, 2025. The Company's fiscal year 2025 guidance outlined below incorporates management's expectations regarding the Company's investments and actions aimed at generating demand, increasing its innovation pipeline and strengthening its execution capabilities, including continued investment in research and development, marketing and talent. The Company's fiscal year 2025 guidance reflects management's expectation that its results for the second quarter of 2025 will reflect a full quarter of the incremental marketing investment that began at the end of the first quarter of 2025. Further, the Company's fiscal year 2025 guidance incorporates the current consumer spending environment and assumes no material impact from tariffs. *Adjusted gross profit margin and adjusted EBITDA margin are non-GAAP measures. See 'Disclosure Regarding Non-GAAP Financial Measures' for additional information. Webcast and Conference Call Information The Company plans to host an investor conference call and webcast to review first quarter 2025 financial results at 9:00am ET/6:00am PT on May 8, 2025. The webcast can be accessed at The conference call can be accessed by calling (201) 689-8521 or (877) 407-8813 for a toll-free number. A replay of the webcast will remain available on the website for 90 days. About OLAPLEX OLAPLEX is a foundational health and beauty company powered by breakthrough innovation and the professional hairstylist. Born in the lab and brought to the chair, our products are designed to enable Pros and their clients to achieve their best results and to provide consumers with a holistic healthy hair regimen. Founded in 2014, OLAPLEX revolutionized prestige hair care with its category creating Complete Bond Technology™, which works by protecting, strengthening and relinking all three bonds during and after hair services. Since then, OLAPLEX has expanded into a full suite of hair health formulas. OLAPLEX's award-winning products are sold globally through an omnichannel model serving the professional, specialty retail, and direct-to-consumer channels. Cautionary Note Regarding Forward-Looking Statements This press release includes certain forward-looking statements and information relating to the Company that are based on the beliefs of management as well as assumptions made by, and information currently available to, the Company. These forward-looking statements include, but are not limited to, statements about: the Company's financial position, operating results, growth, sales and profitability; the Company's financial guidance for fiscal year 2025, including net sales, adjusted gross profit margin and adjusted EBITDA margin; the Company's second quarter 2025 results and marketing investment; demand for the Company's products; the Company's innovation strategy and pipeline, including the timing of product launches; the Company's international operations, including its distribution partners; the Company's business transformation plans, strategies, investments, priorities and objectives, including the impact and timing thereof; the Company's sales, marketing and education initiatives and related investments, and the impact, focus and timing thereof; general economic and industry trends, including tariffs; the Company's infrastructure and operational and business processes; inventory levels; and other statements contained in this press release that are not historical or current facts. When used in this press release, words such as 'may,' 'will,' 'could,' 'should,' 'intend,' 'potential,' 'continue,' 'anticipate,' 'believe,' 'estimate,' 'expect,' 'plan,' 'target,' 'predict,' 'project,' 'forecast,' 'seek' and similar expressions as they relate to the Company are intended to identify forward-looking statements. The forward-looking statements in this press release reflect the Company's current expectations and projections about future events and financial trends that management believes may affect the Company's business, financial condition and results of operations. These statements are predictions based upon assumptions that may not prove to be accurate, and they are not guarantees of future performance. As such, you should not place significant reliance on the Company's forward-looking statements. Neither the Company nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements, including any such statements taken from third party industry and market reports. Forward-looking statements involve known and unknown risks, inherent uncertainties and other factors that are difficult to predict which may cause the Company's actual results, performance, time frames or achievements to be materially different from any future results, performance, time frames or achievements expressed or implied by the forward-looking statements, including, without limitation: the Company's dependence on the success of its business transformation plan; competition in the beauty industry; the Company's ability to effectively maintain and promote a positive brand image, expand its brand awareness and maintain consumer confidence in the quality, safety and efficacy of its products; the Company's ability to anticipate and respond to market trends and changes in consumer preferences and execute on its growth strategies and expansion opportunities, including with respect to new product introductions; the Company's ability to accurately forecast customer and consumer demand for its products; the Company's ability to limit the illegal distribution and sale by third parties of counterfeit versions of its products or the unauthorized diversion by third parties of its products; the Company's dependence on a limited number of customers for a large portion of its net sales; the Company's ability to develop, manufacture and effectively and profitably market and sell future products; the Company's ability to attract new customers and consumers and encourage consumer spending across its product portfolio; the Company's ability to successfully implement new or additional marketing efforts; the Company's relationships with and the performance of its suppliers, manufacturers, distributors and retailers and the Company's ability to manage its supply chain; impacts on the Company's business from political, regulatory, economic, trade and other risks associated with operating internationally; the Company's ability to manage its executive leadership changes and to attract and retain senior management and other qualified personnel; the Company's reliance on its and its third-party service providers' information technology; the Company's ability to maintain the security of confidential information; the Company's ability to establish and maintain intellectual property protection for its products, as well as the Company's ability to operate its business without infringing, misappropriating or otherwise violating the intellectual property rights of others; the outcome of litigation and regulatory proceedings; the impact of changes in federal, state and international laws, regulations and administrative policy, including tariffs and other trade policies; the Company's existing and any future indebtedness, including the Company's ability to comply with affirmative and negative covenants under its credit agreement; the Company's ability to service its existing indebtedness and obtain additional capital to finance operations and its growth opportunities; volatility of the Company's stock price; the Company's 'controlled company' status and the influence of investment funds affiliated with Advent International, L.P. over the Company; the impact of general economic conditions, disruptions in business conditions, and the financial strength of the Company's consumers and customers on the Company's business; fluctuations in the Company's quarterly results of operations; changes in the Company's tax rates and the Company's exposure to tax liability; and the other factors identified under the heading 'Risk Factors' in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the 'SEC') and in the other documents that the Company files with the SEC from time to time. Many of these factors are macroeconomic in nature and are, therefore, beyond the Company's control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance or achievements may vary materially from those described in this press release as anticipated, believed, estimated, expected, intended, planned or projected. The forward-looking statements in this press release represent management's views as of the date hereof. Unless required by law, the Company neither intends nor assumes any obligation to update these forward-looking statements for any reason after the date hereof to conform these statements to actual results or to changes in the Company's expectations or otherwise. Disclosure Regarding Non-GAAP Financial Measures In addition to the financial measures presented in this release in accordance with GAAP, the Company has included certain non-GAAP financial measures, including adjusted EBITDA, adjusted EBITDA margin, adjusted gross profit, adjusted gross profit margin and adjusted SG&A. Management believes these non-GAAP financial measures, when taken together with the Company's financial results presented in accordance with GAAP, provide meaningful supplemental information regarding the Company's operating performance and facilitate internal comparisons of its historical operating performance on a more consistent basis by excluding certain items that may not be indicative of its business, results of operations or outlook. In particular, management believes that the use of these non-GAAP measures may be helpful to investors as they are measures used by management in assessing the health of the Company's business, determining incentive compensation and evaluating its operating performance, as well as for internal planning and forecasting purposes. The Company calculates adjusted EBITDA as net income, adjusted to exclude: (1) interest expense, net; (2) income tax provision; (3) depreciation and amortization; (4) share-based compensation expense; (5) non-ordinary inventory adjustments; (6) certain litigation related expenses; (7) executive reorganization costs and (8) Tax Receivable Agreement liability adjustments. The Company calculates adjusted EBITDA margin by dividing adjusted EBITDA by net sales. The Company calculates adjusted gross profit as gross profit, adjusted to exclude: (1) non-ordinary inventory adjustments and (2) amortization of patented formulations. The Company calculates adjusted gross profit margin by dividing adjusted gross profit by net sales. The Company calculates adjusted SG&A as SG&A, adjusted to exclude: (1) share-based compensation expense; (2) certain litigation related expenses; and (3) executive reorganization costs. Please refer to 'Reconciliation of Non-GAAP Financial Measures to GAAP Equivalents' located in the financial supplement in this release for further information regarding these adjustments for the periods presented. Please refer to 'Reconciliation of Non-GAAP Financial Measures to GAAP Equivalents' located in the financial supplement in this release for a reconciliation of these non-GAAP metrics to their most directly comparable financial measure stated in accordance with GAAP. This release includes forward-looking guidance for adjusted EBITDA margin and adjusted gross profit margin. The Company is not able to provide, without unreasonable effort, a reconciliation of the guidance for adjusted EBITDA margin and adjusted gross profit margin to the most directly comparable GAAP measure because the Company does not currently have sufficient data to accurately estimate the variables and individual adjustments included in the most directly comparable GAAP measure that would be necessary for such reconciliations, including (a) costs related to potential debt or equity transactions and (b) other non-recurring expenses that cannot reasonably be estimated in advance. These adjustments are inherently variable and uncertain and depend on various factors that are beyond the Company's control and as a result it is also unable to predict their probable significance. Therefore, because management cannot estimate on a forward-looking basis without unreasonable effort the impact these variables and individual adjustments will have on its reported results in accordance with GAAP, it is unable to provide a reconciliation of the non-GAAP financial measures included in its fiscal year 2025 guidance. Reconciliation of Non-GAAP Financial Measures to GAAP Equivalents (amounts in thousands) (Unaudited) The following tables present a reconciliation of net income, gross profit and SG&A, as the most directly comparable financial measure stated in accordance with U.S. GAAP, to adjusted EBITDA, adjusted EBITDA margin, adjusted gross profit, adjusted gross profit margin and adjusted SG&A for each of the periods presented. (1) Represents litigation costs related to the Lilien securities class action. The Company considers litigation costs related to the Lilien securities class action, as described in Note 12 to the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2025, to be non-recurring and non-ordinary. While the Company has not previously adjusted for these costs because the amounts incurred in 2024 were not material, commencing with the three months ended March 31, 2025, the Company has included an adjustment for these costs as a result of the court's denial of the Company's motion to dismiss in February 2025. The Company believes adjusting for such costs in the presentation of its adjusted EBITDA, adjusted EBITDA margin and adjusted SG&A provides investors with meaningful information regarding the Company's core operating performance. (2) Represented benefit payments associated with the departure of the Company's Chief Executive Officer that occurred in fiscal year 2023 and Chief Operating Officer that occurred in fiscal year 2022. Contacts: Investors: ICR, Inc. Allison Malkin Partner [email protected] Financial Media: Lisa Bobroff Vice President, Global Communications & Consumer Engagement [email protected]
Yahoo
18-04-2025
- Business
- Yahoo
Firing on All Cylinders: Olaplex (NASDAQ:OLPX) Q4 Earnings Lead the Way
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let's take a look at how Olaplex (NASDAQ:OLPX) and the rest of the personal care stocks fared in Q4. While personal care products products may seem more discretionary than food, consumers tend to maintain or even boost their spending on the category during tough times. This phenomenon is known as "the lipstick effect" by economists, which states that consumers still want some semblance of affordable luxuries like beauty and wellness when the economy is sputtering. Consumer tastes are constantly changing, and personal care companies are currently responding to the public's increased desire for ethically produced goods by featuring natural ingredients in their products. The 13 personal care stocks we track reported a satisfactory Q4. As a group, revenues beat analysts' consensus estimates by 3.7% while next quarter's revenue guidance was 6.9% below. Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 21.2% since the latest earnings results. Rising to fame on TikTok because of its 'bond building" hair products, Olaplex (NASDAQ:OLPX) offers products and treatments that repair the damage caused by traditional heat and chemical-based styling goods. Olaplex reported revenues of $100.7 million, down 9.8% year on year. This print exceeded analysts' expectations by 14.4%. Overall, it was an incredible quarter for the company with a solid beat of analysts' EPS estimates and an impressive beat of analysts' EBITDA estimates. Amanda Baldwin, OLAPLEX's Chief Executive Officer, commented: "I am pleased with our end to the year with our fourth quarter results ahead of the expectations we shared in November. During 2024 we laid a critical foundation for our business and brand transformation and I remain confident and optimistic about the strategies put in place as we step into a meaningful year ahead for the business." Olaplex achieved the biggest analyst estimates beat and highest full-year guidance raise of the whole group. Investor expectations, however, were likely higher than Wall Street's published projections, leaving some wishing for even better results (analysts' consensus estimates are those published by big banks and advisory firms, not the investors who make buy and sell decisions). The stock is down 10.9% since reporting and currently trades at $1.22. Is now the time to buy Olaplex? Access our full analysis of the earnings results here, it's free. Co-founded by actress Jessica Alba, The Honest Company (NASDAQ:HNST) sells diapers and wipes, skin care products, and household cleaning products. The Honest Company reported revenues of $99.84 million, up 10.6% year on year, outperforming analysts' expectations by 3.1%. The business had a stunning quarter with a solid beat of analysts' EPS estimates and an impressive beat of analysts' EBITDA estimates. The stock is down 20.7% since reporting. It currently trades at $4.51. Is now the time to buy The Honest Company? Access our full analysis of the earnings results here, it's free. With a portfolio boasting many household brands, Coty (NYSE:COTY) is a beauty products powerhouse spanning cosmetics, fragrances, and skincare. Coty reported revenues of $1.67 billion, down 3.3% year on year, falling short of analysts' expectations by 3.1%. It was a softer quarter as it posted a miss of analysts' EPS and organic revenue estimates. Coty delivered the weakest performance against analyst estimates in the group. As expected, the stock is down 32.1% since the results and currently trades at $4.60. Read our full analysis of Coty's results here. With person-to-person marketing and sales rather than selling through retail stores, Nu Skin (NYSE:NUS) is a personal care and dietary supplements company that engages in direct selling. Nu Skin reported revenues of $445.6 million, down 8.8% year on year. This print beat analysts' expectations by 2.2%. Aside from that, it was a slower quarter as it logged revenue guidance for next quarter missing analysts' expectations and a significant miss of analysts' gross margin estimates. The stock is down 14.5% since reporting and currently trades at $5.48. Read our full, actionable report on Nu Skin here, it's free. Named after its founder, who was an entrepreneurial woman from New York with a passion for skincare, Estée Lauder (NYSE:EL) is a one-stop beauty shop with products in skincare, fragrance, makeup, sun protection, and men's grooming. Estée Lauder reported revenues of $4.00 billion, down 6.4% year on year. This result surpassed analysts' expectations by 0.7%. Overall, it was a strong quarter as it also produced an impressive beat of analysts' EPS estimates and a solid beat of analysts' EBITDA estimates. The stock is down 34% since reporting and currently trades at $54.62. Read our full, actionable report on Estée Lauder here, it's free. In response to the Fed's rate hikes in 2022 and 2023, inflation has been gradually trending down from its post-pandemic peak, trending closer to the Fed's 2% target. Despite higher borrowing costs, the economy has avoided flashing recessionary signals. This is the much-desired soft landing that many investors hoped for. The recent rate cuts (0.5% in September and 0.25% in November 2024) have bolstered the stock market, making 2024 a strong year for equities. Donald Trump's presidential win in November sparked additional market gains, sending indices to record highs in the days following his victory. However, debates continue over possible tariffs and corporate tax adjustments, raising questions about economic stability in 2025. Want to invest in winners with rock-solid fundamentals? Check out our Hidden Gem Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Join Paid Stock Investor Research Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here.
Yahoo
25-02-2025
- Business
- Yahoo
OLAPLEX Unveils Next Chapter With a Bold Vision for Foundational Hair Health and Innovation-Led Future
Pioneering bond-building brand redefines hair health with a new brand identity, groundbreaking innovation in scalp, and a commitment to empowering stylists worldwide. NEW YORK, Feb. 25, 2025 /PRNewswire/ -- OLAPLEX Holdings, Inc. ("OLAPLEX"), the foundational health and beauty brand and pioneer of bond-building hair care, is entering a bold new chapter rooted in its legacy of category-creating science and inspired by the creativity and the passion of professional stylists. Born in the lab and made famous in the chair, OLAPLEX has spent the last decade transforming hair health from the inside out with its innovative Complete Bond Technology™, renowned for its unmatched ability to repair hair's bonds. "From day one, OLAPLEX has built bonds and broken barriers," said Amanda Baldwin, CEO of OLAPLEX. "This new chapter is about living up to the extraordinary innovation that has always defined us. Our products will repair and transform in the most extraordinary of circumstances but it's their daily power to build foundational hair health and deliver lasting results that makes them truly breakthrough and empowers stylists and customers with the confidence that comes from truly healthy hair." OLAPLEX's refreshed identity also brings the brand's core values to life through vibrant new visuals, a dynamic digital presence, and a continued belief in the bond between science and style. "We want those two sides of our brand to come forward in our visual identity. We believe that it's a true expression of the confidence in our heritage, our bold approach to innovation, and our passion for the creativity of the professional community. It's a reflection of not only who we've always been, but also an introduction to our future." Since its inception, OLAPLEX has been embraced by the stylist community. This reaffirms its commitment to providing science-backed tools that elevate artistry and deliver exceptional results. Harnessing the power of its category leading bond-building technology, OLAPLEX continues to innovate beyond damage repair to unlock foundational hair health. With this science-first approach, OLAPLEX is dedicated to equipping professionals with the tools to transform hair while giving consumers the freedom to style without compromise. "Today's professionals and consumers are more knowledgeable than ever about the science of haircare. Foundational hair health is, and always has been, in service of letting the work of the pro community truly shine and to deliver more great hair days, today, tomorrow and for years to come," Baldwin added. Innovating Beyond Repair: No.0.5 Scalp Longevity Treatment As part of this exciting evolution, OLAPLEX introduces the No.0.5 Scalp Longevity Treatment—a unique scalp serum designed to establish the foundation for long-term scalp and hair health. Combined with bestselling No.3 Hair Perfector this innovation is emblematic of OLAPLEX's new vision and its promise to deliver lasting hair health from root to tip. The next chapter is the beginning of a new era for OLAPLEX and for haircare—one where true hair health takes center stage, unlocking beautifully healthy hair for today, tomorrow, and years to come. ABOUT OLAPLEXOLAPLEX is a foundational health and beauty company powered by breakthrough innovation and the professional hairstylist. Born in the lab and brought to the chair, our products are designed to enable Pros and their clients to achieve their best results and to provide consumers with a holistic healthy hair regimen. Founded in 2014, OLAPLEX revolutionized prestige hair care with its category creating Complete Bond Technology™, which works by protecting, strengthening and relinking all three bonds during and after hair services. Since then, OLAPLEX has expanded into a full suite of hair health formulas. OLAPLEX's award-winning products are sold globally through an omnichannel model serving the professional, specialty retail, and direct-to-consumer channels. Media Contact olaplex@ View original content to download multimedia: SOURCE OLAPLEX Sign in to access your portfolio
